Benemid: Effective Uric Acid Control for Gout Management
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.81 | $48.47 (0%) | 🛒 Add to cart |
| 90 | $0.70
Best per pill | $72.70 $62.60 (14%) | 🛒 Add to cart |
Synonyms | |||
Benemid (probenecid) is a well-established uricosuric agent prescribed for the chronic management of hyperuricemia associated with gout and gouty arthritis. By increasing the urinary excretion of uric acid, it effectively reduces serum urate levels, helping to prevent the formation of painful tophi and recurrent gout attacks. This medication is a cornerstone in long-term gout prophylaxis, particularly for patients who are under-excretors of uric acid and have not responded adequately to lifestyle modifications or other first-line therapies. Its mechanism provides a targeted physiological approach to managing the underlying metabolic dysfunction responsible for gout symptomatology.
Features
- Active ingredient: Probenecid 500 mg
- Pharmaceutical class: Uricosuric agent
- Administration: Oral tablet
- Standard packaging: 100 tablets per bottle
- Prescription-only medication
- Compatible with certain penicillin-class antibiotics to increase their plasma concentration
Benefits
- Significantly reduces serum uric acid levels by enhancing renal excretion
- Prevents formation of new urate crystals and tophi in joints and tissues
- Decreases frequency and severity of acute gout attacks with continued use
- May lead to gradual resolution of existing tophi over extended therapy
- Enables reduced dosage requirements for concomitant penicillin antibiotics
- Provides a non-allopurinol alternative for patients with hypersensitivity or contraindications
Common use
Benemid is primarily indicated for the treatment of chronic gout and gouty arthritis in patients who overproduce uric acid or are under-excretors. It is particularly valuable for patients who have experienced multiple acute attacks annually or who have developed visible tophi. The medication is also used as an adjunct to antibiotic therapy, specifically to elevate and prolong plasma concentrations of penicillin and related antibiotics in treatments requiring high antibiotic levels.
Dosage and direction
Initial adult dosage for gout is 250 mg twice daily for one week, followed by 500 mg twice daily. Maintenance dosage may be increased by 500 mg every 4 weeks, if necessary, up to a maximum of 2-3 grams daily divided into 2-4 doses. For antibiotic potentiation, typical adult dosage is 2 grams daily in divided doses. Administration should be accompanied by adequate fluid intake (minimum 2 liters daily) to minimize risk of uric acid stone formation. Tablets should be taken with food or milk to reduce gastrointestinal discomfort.
Precautions
Regular monitoring of serum uric acid levels and renal function is recommended during therapy. Patients should maintain adequate hydration throughout treatment. Use with caution in patients with history of peptic ulcer disease or blood dyscrasias. May precipitate acute gout attacks during initial treatment phase; concurrent colchicine or NSAID prophylaxis is often recommended during the first 3-6 months of therapy. Not recommended for treatment of asymptomatic hyperuricemia.
Contraindications
Hypersensitivity to probenecid or any component of the formulation. Not recommended for children under 2 years of age. Contraindicated in patients with blood dyscrasias or uric acid kidney stones. Should not be used during acute gout attacks until inflammation has subsided. Contraindicated in patients with known glucose-6-phosphate dehydrogenase (G6PD) deficiency due to risk of hemolysis.
Possible side effects
Common: Gastrointestinal disturbances (nausea, vomiting, anorexia), headache, dizziness, frequent urination. Less common: Hypersensitivity reactions (skin rash, pruritus), flushing, sore gums, anemia. Rare: Nephrotic syndrome, hepatic necrosis, aplastic anemia. Acute gout attacks may occur during initial therapy as uric acid mobilizes from tissues.
Drug interaction
Significantly increases plasma levels of penicillin, indomethacin, naproxen, and methotrexate. May increase activity of oral hypoglycemic agents. Salicylates in doses exceeding 1-2 grams daily antagonize uricosuric effect. Diuretics may decrease effectiveness of Benemid. Alcohol consumption may increase uric acid levels and decrease drug efficacy.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent uric acid control.
Overdose
Symptoms may include nausea, vomiting, dizziness, and convulsions. Management includes gastric lavage if ingestion was recent and supportive care. Maintain adequate urine flow and alkalization of urine may help prevent uric acid crystallization. There is no specific antidote; hemodialysis may be effective due to the drug’s protein binding characteristics.
Storage
Store at controlled room temperature (20-25°C or 68-77°F) in a tightly closed container. Protect from light and moisture. Keep out of reach of children and pets. Do not use after expiration date printed on packaging.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult with a qualified healthcare provider before starting or changing any medication regimen. Individual response to medication may vary, and proper medical supervision is essential for safe and effective treatment.
Reviews
Clinical studies demonstrate Benemid effectively reduces serum urate levels by 30-50% in responsive patients. Long-term studies show significant reduction in gout attack frequency and tophi resolution over 6-12 months of consistent therapy. Patient satisfaction surveys indicate improved quality of life scores among compliant users, though gastrointestinal side effects remain the most commonly reported concern requiring management.